In contrast, the PVS incidence in the BAY-876-treated group was significantly higher than in nontreated IG27 glioma (Figure 6B), which is similar to the progression and invasion phenotype of Glut1-KD IG27 glioma (Figure 5A and B). This evidence concerns the gene SLC2A1 and central nervous system cancer.